MedTrace Logo

Preloaded Combination Nicotine Replacement Therapy on Smoking Cessation of Adult Population in Kazakhstan

NCT05484505 · Status: UNKNOWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2023-03-24

No results posted yet for this study

Summary

Randomized, controlled, two-armed, single-blinded, superiority trial with 1:1 allocation ratio Nicotine Replacement Therapy(NRT)

Conditions

  • Smoking Cessation
  • Smoking, Cigarette
  • Smoking Behaviors

Interventions

DRUG

Nicotine patch, Nicotine gums

Nicotine patch 21mg, 12 weeks post quit date and nicotine chewing gums 4mg for 12 weeks post quit date * 14 mg: Next 4 weeks * 7 mg: Last 4 weeks

BEHAVIORAL

Brief Advice (5 A's & 5 R's)

Brief Advice (5 A's \& 5 R's) at Day 0, 1 month, 3,6,9 \& 12 months

DRUG

Nicotine Patch: Preloading for 4 weeks

Nicotine Patch: Preloading for 4 weeks - 21 mg: 4 weeks before quit date

Sponsors & Collaborators

  • Astana Medical University

    collaborator OTHER

  • Nazarbayev University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-07-01
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • Kazakhstan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05484505 on ClinicalTrials.gov